Page last updated: 2024-08-21

cyclopentane and B16 Melanoma

cyclopentane has been researched along with B16 Melanoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's3 (27.27)18.2507
2000's4 (36.36)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, HY; Jung, HJ; Jung, YS; Kang, D; Lee, AK; Lee, S; Moon, HR; Park, YJ1
Li, H; Sun, Y; Tan, M1
Chang, ST; Chu, FH; Kumar, KJ; Wang, SY; Yang, JC1
Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ1
Bertrand, M; Casara, P; Chollet, AM; Guilbaud, N; Hennig, P; Le Diguarher, T; Pierré, A; Raimbaud, E; Sabatini, M; Tucker, GC1
Huh, CH; Kim, DS; Kim, WG; Lee, DH; Park, KC; Park, SH; Ryoo, IJ; Yoo, ID; Youn, SW1
Flescher, E; Heyfets, A; Kashman, Y; Nordenberg, J; Reischer, D; Shimony, S1
Chung, MC; Kho, YH; Koshino, H; Lee, CH; Lee, HJ1
Bae, KS; Chung, MC; Kho, YH; Lee, CH; Lee, HJ1
Nakamura, H; Sekido, M; Yamamoto, Y1
Klapötke, T; Köpf-Maier, P1

Other Studies

11 other study(ies) available for cyclopentane and B16 Melanoma

ArticleYear
(2
    Molecules (Basel, Switzerland), 2018, 06-11, Volume: 23, Issue:6

    Topics: Animals; Cyclopentanes; Down-Regulation; Fibroblasts; Melanins; Melanoma, Experimental; Mice; Phosphorylation; Skin Aging; Ultraviolet Rays

2018
Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
    Oncogene, 2014, Oct-30, Volume: 33, Issue:44

    Topics: Animals; Carrier Proteins; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Cyclopentanes; Embryo Loss; Endothelial Cells; Gene Deletion; Gene Knockdown Techniques; Melanoma, Experimental; Mice, Knockout; NEDD8 Protein; Neovascularization, Pathologic; Pyrimidines; Ubiquitin-Protein Ligases; Ubiquitins

2014
Lucidone, a novel melanin inhibitor from the fruit of Lindera erythrocarpa Makino.
    Phytotherapy research : PTR, 2010, Volume: 24, Issue:8

    Topics: Agaricales; Animals; Cyclopentanes; Gene Expression Regulation; Lindera; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2010
Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl)cyclopent-2-ene-1-one.
    Bioorganic & medicinal chemistry, 2003, Mar-20, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents; Body Weight; Chromatography, High Pressure Liquid; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Prodrugs; Solubility; Tumor Cells, Cultured

2003
Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
    Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Caco-2 Cells; Cyclopentanes; Humans; In Vitro Techniques; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Microsomes, Liver; Models, Molecular; Molecular Conformation; Neoplasm Metastasis; Permeability; Phthalimides; Protease Inhibitors; Stereoisomerism; Structure-Activity Relationship; Triazines

2003
Terrein: a new melanogenesis inhibitor and its mechanism.
    Cellular and molecular life sciences : CMLS, 2004, Volume: 61, Issue:22

    Topics: Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cyclopentanes; DNA-Binding Proteins; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Luciferases; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Penicillium; Transcription Factors

2004
Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma.
    British journal of pharmacology, 2007, Volume: 150, Issue:6

    Topics: Acetates; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclopentanes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxylipins

2007
MR304A, a new melanin synthesis inhibitor produced by Trichoderma harzianum.
    The Journal of antibiotics, 1995, Volume: 48, Issue:10

    Topics: Basidiomycota; Cyclopentanes; Fermentation; Melanins; Melanoma, Experimental; Molecular Conformation; Monophenol Monooxygenase; Nitriles; Trichoderma

1995
MR566A and MR566B, new melanin synthesis inhibitors produced by Trichoderma harzianum. I. Taxonomy, fermentation, isolation and biological activities.
    The Journal of antibiotics, 1997, Volume: 50, Issue:6

    Topics: Animals; Basidiomycota; Cyclopentanes; Enzyme Inhibitors; Fermentation; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Nitriles; Streptomyces; Trichoderma; Tumor Cells, Cultured

1997
Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers.
    Journal of medicinal chemistry, 1997, Aug-29, Volume: 40, Issue:18

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azulenes; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Survival; Cycloheptanes; Cyclopentanes; Drug Carriers; Drug Screening Assays, Antitumor; Melanoma, Experimental; Mice

1997
Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclopentanes; Female; Iron; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Organometallic Compounds; Sarcoma 180

1989